REDMILE GROUP, LLC Holdings

REDMILE GROUP, LLC is an investment fund managing more than 2.58B US dollars. The largest holdings include Fate Therapeutics, Amicus Therapeutics and Krystal Biotech. In Q3 2022 the fund bought assets of total value of 422.23M US dollars and sold assets of total value of 400.93M US dollars.

$2.57B

portfolio value

+3.09%

quarter

-50.83%

1 year

-30.02%

3 years

-71.13%

5 years

REDMILE GROUP, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	104903000	397777000
Q2 2016	214675000	148844000
Q3 2016	420679000	183619000
Q4 2016	153906000	230096000
Q1 2017	536319000	86975000
Q2 2017	349308000	312431000
Q3 2017	667215000	337054000
Q4 2017	522954000	305592000
Q1 2018	601317000	368721000
Q2 2018	662424000	241763000
Q3 2018	811996000	408778000
Q4 2018	239600000	856227000
Q1 2019	936457000	104013000
Q2 2019	517262000	583520000
Q3 2019	547288000	669346000
Q4 2019	1613412000	285382000
Q1 2020	364681000	1000757000
Q2 2020	1710446000	13068000
Q3 2020	985532000	843068000
Q4 2020	2163599000	214967000
Q1 2021	594181000	1525914000
Q2 2021	417061000	686607000
Q3 2021	595629000	1021543000
Q4 2021	473438000	1682415000
Q1 2022	-52299000	628168000
Q2 2022	126469000	326767000
Q3 2022	422229000	400925000

REDMILE GROUP, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Fate Therapeutics, Inc. Portfolio share: 11.26% Portfolio value: 290.37M Avg. open price: $12.45 Current price: $20.4 P/L: +63.80% Bought +2.59% shares Q1 2021	share	11.26%	290.37M	$12.45	$20.4	+63.80%	Bought +2.59% shares Q1 2021
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 8.80% Portfolio value: 226.74M Avg. open price: $10.02 Current price: $12.37 P/L: +23.43% Sold -1.98% shares Q3 2022	share	8.80%	226.74M	$10.02	$12.37	+23.43%	Sold -1.98% shares Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 5.14% Portfolio value: 132.39M Avg. open price: $43.61 Current price: $75.78 P/L: +73.76% Bought +0.05% shares Q3 2022	share	5.14%	132.39M	$43.61	$75.78	+73.76%	Bought +0.05% shares Q3 2022
Biotechnology argenx SE Portfolio share: 3.83% Portfolio value: 98.86M Avg. open price: $86.99 Current price: $393.21 P/L: +352.03% Sold -27.42% shares Q3 2022	share	3.83%	98.86M	$86.99	$393.21	+352.03%	Sold -27.42% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 3.65% Portfolio value: 94.17M Avg. open price: $8.01 Current price: $17 P/L: +112.23% Bought +46.89% shares Q3 2022	share	3.65%	94.17M	$8.01	$17	+112.23%	Bought +46.89% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 3.32% Portfolio value: 85.57M Avg. open price: $30.42 Current price: $38.83 P/L: +27.65% Bought +44.61% shares Q3 2022	share	3.32%	85.57M	$30.42	$38.83	+27.65%	Bought +44.61% shares Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 3.28% Portfolio value: 84.46M Avg. open price: $25.59 Current price: $44.37 P/L: +73.37% Sold -4.16% shares Q3 2022	share	3.28%	84.46M	$25.59	$44.37	+73.37%	Sold -4.16% shares Q3 2022
Medical Devices LivaNova PLC Portfolio share: 3.03% Portfolio value: 78.00M Avg. open price: $78.79 Current price: $55.1 P/L: -30.07% Sold -5.38% shares Q3 2022	share	3.03%	78.00M	$78.79	$55.1	-30.07%	Sold -5.38% shares Q3 2022
Biotechnology IGM Biosciences, Inc. Portfolio share: 2.94% Portfolio value: 75.82M Avg. open price: $73 Current price: $20.05 P/L: -72.53% Sold -2.66% shares Q4 2021	share	2.94%	75.82M	$73	$20.05	-72.53%	Sold -2.66% shares Q4 2021
Health Information Services 1Life Healthcare, Inc. Portfolio share: 2.72% Portfolio value: 70.10M Avg. open price: $26.48 Current price: $16.74 P/L: -36.79% Sold -9.60% shares Q3 2022	share	2.72%	70.10M	$26.48	$16.74	-36.79%	Sold -9.60% shares Q3 2022
Biotechnology Replimune Group, Inc. Portfolio share: 2.44% Portfolio value: 62.95M Avg. open price: $20 Current price: $19.95 P/L: -0.23% Sold -1.25% shares Q2 2022	share	2.44%	62.95M	$20	$19.95	-0.23%	Sold -1.25% shares Q2 2022
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 2.43% Portfolio value: 62.62M Avg. open price: $35.32 Current price: $29.11 P/L: -17.58% Bought +10.34% shares Q3 2022	share	2.43%	62.62M	$35.32	$29.11	-17.58%	Bought +10.34% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 2.37% Portfolio value: 60.99M Avg. open price: $9.74 Current price: $21.89 P/L: +124.64% Bought +123.84% shares Q3 2022	share	2.37%	60.99M	$9.74	$21.89	+124.64%	Bought +123.84% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 2.16% Portfolio value: 55.80M Avg. open price: $16.8 Current price: $36.66 P/L: +118.23% Sold -4.11% shares Q3 2022	share	2.16%	55.80M	$16.8	$36.66	+118.23%	Sold -4.11% shares Q3 2022
Drug Manufacturers—Specialty & Generic Deciphera Pharmaceuticals, Inc. Portfolio share: 2.13% Portfolio value: 55.00M Avg. open price: $21.54 Current price: $15.02 P/L: -30.27% Bought +107.77% shares Q3 2022	share	2.13%	55.00M	$21.54	$15.02	-30.27%	Bought +107.77% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 2.10% Portfolio value: 54.17M Avg. open price: $25.46 Current price: $44.04 P/L: +73.01% Bought +0.24% shares Q3 2022	share	2.10%	54.17M	$25.46	$44.04	+73.01%	Bought +0.24% shares Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 2.01% Portfolio value: 51.70M Avg. open price: $37.72 Current price: $21.42 P/L: -43.21% Sold -17.91% shares Q3 2022	share	2.01%	51.70M	$37.72	$21.42	-43.21%	Sold -17.91% shares Q3 2022
Biotechnology REGENXBIO Inc. Portfolio share: 1.97% Portfolio value: 50.67M Avg. open price: $39.94 Current price: $23.04 P/L: -42.31% Sold -4.36% shares Q3 2022	share	1.97%	50.67M	$39.94	$23.04	-42.31%	Sold -4.36% shares Q3 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.85% Portfolio value: 47.65M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	1.85%	47.65M	N/A	$28.09	N/A	N/A Q3 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 1.58% Portfolio value: 40.86M Avg. open price: $6.51 Current price: $5.43 P/L: -16.53% Sold -6.49% shares Q3 2022	share	1.58%	40.86M	$6.51	$5.43	-16.53%	Sold -6.49% shares Q3 2022
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 1.52% Portfolio value: 39.17M Avg. open price: $33.31 Current price: $12.38 P/L: -62.84% Sold -0.40% shares Q2 2022	share	1.52%	39.17M	$33.31	$12.38	-62.84%	Sold -0.40% shares Q2 2022
Biotechnology ADC Therapeutics SA Portfolio share: 1.40% Portfolio value: 36.20M Avg. open price: $36.61 Current price: $3.52 P/L: -90.39% Bought +1.07% shares Q2 2022	share	1.40%	36.20M	$36.61	$3.52	-90.39%	Bought +1.07% shares Q2 2022
Biotechnology Zymeworks Inc. Portfolio share: 1.38% Portfolio value: 35.46M Avg. open price: $10.18 Current price: $7.62 P/L: -25.16% Bought +50.32% shares Q3 2022	share	1.38%	35.46M	$10.18	$7.62	-25.16%	Bought +50.32% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 1.31% Portfolio value: 33.89M Avg. open price: $100.2 Current price: $212 P/L: +111.57% N/A Q3 2022	share	1.31%	33.89M	$100.2	$212	+111.57%	N/A Q3 2022
Biotechnology Repare Therapeutics Inc. Portfolio share: 1.26% Portfolio value: 32.56M Avg. open price: $28.9 Current price: $16.49 P/L: -42.94% Sold -1.35% shares Q3 2022	share	1.26%	32.56M	$28.9	$16.49	-42.94%	Sold -1.35% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 1.24% Portfolio value: 32.01M Avg. open price: $491.22 Current price: $522.34 P/L: +6.34% Sold -16.07% shares Q3 2022	share	1.24%	32.01M	$491.22	$522.34	+6.34%	Sold -16.07% shares Q3 2022
Health Information Services Science 37 Holdings, Inc. Portfolio share: 1.24% Portfolio value: 31.89M Avg. open price: N/A Current price: $0.61 P/L: N/A N/A Q4 2021	share	1.24%	31.89M	N/A	$0.61	N/A	N/A Q4 2021
Biotechnology Prothena Corporation plc Portfolio share: 1.24% Portfolio value: 31.86M Avg. open price: $41.75 Current price: $60.39 P/L: +44.63% Sold -28.61% shares Q3 2022	share	1.24%	31.86M	$41.75	$60.39	+44.63%	Sold -28.61% shares Q3 2022
Medical Devices Stryker Corporation Portfolio share: 1.24% Portfolio value: 31.86M Avg. open price: N/A Current price: $237.9 P/L: N/A N/A Q3 2022	share	1.24%	31.86M	N/A	$237.9	N/A	N/A Q3 2022
Biotechnology Entrada Therapeutics, Inc. Portfolio share: 1.19% Portfolio value: 30.80M Avg. open price: N/A Current price: $17.96 P/L: N/A Sold -0.00% shares Q1 2022	share	1.19%	30.80M	N/A	$17.96	N/A	Sold -0.00% shares Q1 2022
Pharmaceutical Retailers MedAvail Holdings, Inc. Portfolio share: 1.04% Portfolio value: 26.85M Avg. open price: $1.19 Current price: $0.4 P/L: -66.93% Bought +37.36% shares Q3 2022	share	1.04%	26.85M	$1.19	$0.4	-66.93%	Bought +37.36% shares Q3 2022
Medical Care Facilities Oak Street Health, Inc. Portfolio share: 1.01% Portfolio value: 26.02M Avg. open price: $43.08 Current price: $21.94 P/L: -49.07% Sold -23.30% shares Q3 2022	share	1.01%	26.02M	$43.08	$21.94	-49.07%	Sold -23.30% shares Q3 2022
Biotechnology Absci Corporation Portfolio share: 0.97% Portfolio value: 25.13M Avg. open price: N/A Current price: $2.4 P/L: N/A N/A Q3 2021	share	0.97%	25.13M	N/A	$2.4	N/A	N/A Q3 2021
Household & Personal Products The Beauty Health Company Portfolio share: 0.96% Portfolio value: 24.87M Avg. open price: $17.97 Current price: $11.03 P/L: -38.63% Sold -59.32% shares Q3 2022	share	0.96%	24.87M	$17.97	$11.03	-38.63%	Sold -59.32% shares Q3 2022
Biotechnology Atara Biotherapeutics, Inc. Portfolio share: 0.92% Portfolio value: 23.59M Avg. open price: $18.22 Current price: $4.65 P/L: -74.47% Sold -0.05% shares Q2 2022	share	0.92%	23.59M	$18.22	$4.65	-74.47%	Sold -0.05% shares Q2 2022
Healthcare Plans Centene Corporation Portfolio share: 0.85% Portfolio value: 21.97M Avg. open price: $47.87 Current price: $86.35 P/L: +80.38% Sold -56.64% shares Q3 2022	share	0.85%	21.97M	$47.87	$86.35	+80.38%	Sold -56.64% shares Q3 2022
Biotechnology Scholar Rock Holding Corporation Portfolio share: 0.84% Portfolio value: 21.76M Avg. open price: $19.18 Current price: $7.67 P/L: -60.01% Sold -7.75% shares Q3 2022	share	0.84%	21.76M	$19.18	$7.67	-60.01%	Sold -7.75% shares Q3 2022
Biotechnology Annexon, Inc. Portfolio share: 0.84% Portfolio value: 21.65M Avg. open price: $4 Current price: $5.74 P/L: +43.42% Bought +9.37% shares Q2 2022	share	0.84%	21.65M	$4	$5.74	+43.42%	Bought +9.37% shares Q2 2022
Health Information Services Augmedix, Inc. Portfolio share: 0.81% Portfolio value: 20.85M Avg. open price: N/A Current price: $1.17 P/L: N/A N/A Q4 2021	share	0.81%	20.85M	N/A	$1.17	N/A	N/A Q4 2021
Biotechnology RAPT Therapeutics, Inc. Portfolio share: 0.73% Portfolio value: 18.88M Avg. open price: $21.99 Current price: $16.53 P/L: -24.83% Sold -4.04% shares Q3 2022	share	0.73%	18.88M	$21.99	$16.53	-24.83%	Sold -4.04% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 0.70% Portfolio value: 18.03M Avg. open price: N/A Current price: $38.98 P/L: N/A N/A Q3 2022	share	0.70%	18.03M	N/A	$38.98	N/A	N/A Q3 2022
Biotechnology Gritstone bio, Inc. Portfolio share: 0.69% Portfolio value: 17.86M Avg. open price: $12.31 Current price: $2.87 P/L: -76.69% Bought +1.18% shares Q2 2022	share	0.69%	17.86M	$12.31	$2.87	-76.69%	Bought +1.18% shares Q2 2022
Medical Instruments & Supplies Stevanato Group S.p.A. Portfolio share: 0.62% Portfolio value: 16.03M Avg. open price: N/A Current price: $15.64 P/L: N/A Sold -15.15% shares Q3 2022	share	0.62%	16.03M	N/A	$15.64	N/A	Sold -15.15% shares Q3 2022
Biotechnology Allakos Inc. Portfolio share: 0.60% Portfolio value: 15.57M Avg. open price: $40.54 Current price: $8.14 P/L: -79.94% Sold -0.57% shares Q2 2022	share	0.60%	15.57M	$40.54	$8.14	-79.94%	Sold -0.57% shares Q2 2022
Biotechnology Shattuck Labs, Inc. Portfolio share: 0.59% Portfolio value: 15.17M Avg. open price: N/A Current price: $2.28 P/L: N/A N/A Q4 2020	share	0.59%	15.17M	N/A	$2.28	N/A	N/A Q4 2020
Biotechnology AlloVir, Inc. Portfolio share: 0.58% Portfolio value: 15.05M Avg. open price: $3.9 Current price: $7.22 P/L: +85.13% Bought +131.73% shares Q3 2022	share	0.58%	15.05M	$3.9	$7.22	+85.13%	Bought +131.73% shares Q3 2022
Biotechnology LAVA Therapeutics N.V. Portfolio share: 0.50% Portfolio value: 12.87M Avg. open price: N/A Current price: $6.17 P/L: N/A Sold -0.29% shares Q2 2021	share	0.50%	12.87M	N/A	$6.17	N/A	Sold -0.29% shares Q2 2021
Biotechnology Revolution Medicines, Inc. Portfolio share: 0.48% Portfolio value: 12.32M Avg. open price: N/A Current price: $24.32 P/L: N/A N/A Q3 2022	share	0.48%	12.32M	N/A	$24.32	N/A	N/A Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 0.42% Portfolio value: 10.85M Avg. open price: $146.92 Current price: $150.97 P/L: +2.76% Sold -12.65% shares Q3 2022	share	0.42%	10.85M	$146.92	$150.97	+2.76%	Sold -12.65% shares Q3 2022
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.42% Portfolio value: 10.73M Avg. open price: $27.51 Current price: $7.16 P/L: -73.97% Sold -58.07% shares Q3 2022	share	0.42%	10.73M	$27.51	$7.16	-73.97%	Sold -58.07% shares Q3 2022
Medical Devices Bioventus Inc. Portfolio share: 0.35% Portfolio value: 9.09M Avg. open price: $14.91 Current price: $2.25 P/L: -84.91% Sold -0.55% shares Q3 2022	share	0.35%	9.09M	$14.91	$2.25	-84.91%	Sold -0.55% shares Q3 2022
Medical Devices Cutera, Inc. Portfolio share: 0.34% Portfolio value: 8.87M Avg. open price: N/A Current price: $51.65 P/L: N/A N/A Q3 2022	share	0.34%	8.87M	N/A	$51.65	N/A	N/A Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 0.32% Portfolio value: 8.22M Avg. open price: N/A Current price: $547.42 P/L: N/A N/A Q3 2022	share	0.32%	8.22M	N/A	$547.42	N/A	N/A Q3 2022
Medical Care Facilities The Oncology Institute, Inc. Portfolio share: 0.28% Portfolio value: 7.33M Avg. open price: N/A Current price: $1.33 P/L: N/A Sold -8.81% shares Q3 2022	share	0.28%	7.33M	N/A	$1.33	N/A	Sold -8.81% shares Q3 2022
Biotechnology ALX Oncology Holdings Inc. Portfolio share: 0.28% Portfolio value: 7.19M Avg. open price: $39.28 Current price: $11.92 P/L: -69.66% Sold -1.92% shares Q3 2022	share	0.28%	7.19M	$39.28	$11.92	-69.66%	Sold -1.92% shares Q3 2022
Biotechnology Nuvation Bio Inc. Portfolio share: 0.26% Portfolio value: 6.78M Avg. open price: N/A Current price: $1.94 P/L: N/A Sold -12.69% shares Q3 2022	share	0.26%	6.78M	N/A	$1.94	N/A	Sold -12.69% shares Q3 2022
Biotechnology HOOKIPA Pharma Inc. Portfolio share: 0.24% Portfolio value: 6.11M Avg. open price: $3.18 Current price: $0.95 P/L: -70.13% Sold -1.60% shares Q2 2022	share	0.24%	6.11M	$3.18	$0.95	-70.13%	Sold -1.60% shares Q2 2022
Biotechnology Invivyd, Inc. Portfolio share: 0.23% Portfolio value: 6.01M Avg. open price: N/A Current price: $2.13 P/L: N/A Sold -40.84% shares Q4 2021	share	0.23%	6.01M	N/A	$2.13	N/A	Sold -40.84% shares Q4 2021
Diagnostics & Research Invitae Corporation Portfolio share: 0.22% Portfolio value: 5.61M Avg. open price: $31.57 Current price: $2.73 P/L: -91.35% Sold -40.07% shares Q3 2022	share	0.22%	5.61M	$31.57	$2.73	-91.35%	Sold -40.07% shares Q3 2022
Health Information Services SomaLogic, Inc. Portfolio share: 0.21% Portfolio value: 5.42M Avg. open price: $12.39 Current price: $2.7 P/L: -78.21% Sold -10.43% shares Q3 2022	share	0.21%	5.42M	$12.39	$2.7	-78.21%	Sold -10.43% shares Q3 2022
Biotechnology Achilles Therapeutics plc Portfolio share: 0.14% Portfolio value: 3.63M Avg. open price: N/A Current price: $1.71 P/L: N/A Sold -22.99% shares Q1 2022	share	0.14%	3.63M	N/A	$1.71	N/A	Sold -22.99% shares Q1 2022
Medical Instruments & Supplies Stereotaxis, Inc. Portfolio share: 0.10% Portfolio value: 2.67M Avg. open price: $5.09 Current price: $2.23 P/L: -56.19% Sold -12.41% shares Q1 2022	share	0.10%	2.67M	$5.09	$2.23	-56.19%	Sold -12.41% shares Q1 2022
Drug Manufacturers—Specialty & Generic Neoleukin Therapeutics, Inc. Portfolio share: 0.09% Portfolio value: 2.2M Avg. open price: $12.57 Current price: $0.43 P/L: -96.56% Sold -0.82% shares Q2 2022	share	0.09%	2.2M	$12.57	$0.43	-96.56%	Sold -0.82% shares Q2 2022
Biotechnology TCR2 Therapeutics Inc. Portfolio share: 0.08% Portfolio value: 1.97M Avg. open price: $20.66 Current price: $1.37 P/L: -93.37% Sold -18.68% shares Q1 2022	share	0.08%	1.97M	$20.66	$1.37	-93.37%	Sold -18.68% shares Q1 2022
Drug Manufacturers—Specialty & Generic Alpha Teknova, Inc. Portfolio share: 0.07% Portfolio value: 1.86M Avg. open price: N/A Current price: $4.76 P/L: N/A Sold -1.71% shares Q3 2022	share	0.07%	1.86M	N/A	$4.76	N/A	Sold -1.71% shares Q3 2022
Biotechnology Xeris Biopharma Holdings, Inc. Portfolio share: 0.06% Portfolio value: 1.63M Avg. open price: $17 Current price: $1.52 P/L: -91.06% N/A Q4 2021	share	0.06%	1.63M	$17	$1.52	-91.06%	N/A Q4 2021
Biotechnology Atreca, Inc. Portfolio share: 0.05% Portfolio value: 1.25M Avg. open price: $21.23 Current price: $1 P/L: -95.31% Sold -31.60% shares Q4 2021	share	0.05%	1.25M	$21.23	$1	-95.31%	Sold -31.60% shares Q4 2021
Medical Devices Sonendo, Inc. Portfolio share: 0.02% Portfolio value: 533K Avg. open price: N/A Current price: $2.63 P/L: N/A N/A Q4 2021	share	0.02%	533K	N/A	$2.63	N/A	N/A Q4 2021
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.02% Portfolio value: 453K Avg. open price: N/A Current price: $4.97 P/L: N/A Sold -0.00% shares Q3 2021	share	0.02%	453K	N/A	$4.97	N/A	Sold -0.00% shares Q3 2021
Medical Devices Cytosorbents Corporation Portfolio share: 0.01% Portfolio value: 362K Avg. open price: $7.97 Current price: $1.3 P/L: -83.69% Sold -62.86% shares Q1 2022	share	0.01%	362K	$7.97	$1.3	-83.69%	Sold -62.86% shares Q1 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.78 Current price: $98.48 P/L: +454.02% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.78	$98.48	+454.02%	Sold -100.00% shares Q3 2022
Biotechnology Ayala Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.52 Current price: $0.62 P/L: -94.62% Sold -100.00% shares Q3 2022	share	0.00%	0	$11.52	$0.62	-94.62%	Sold -100.00% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $103.53 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$103.53	N/A	Sold -100.00% shares Q3 2022
Medical Devices Nevro Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $78.83 Current price: $43.47 P/L: -44.86% Sold -100.00% shares Q3 2022	share	0.00%	0	$78.83	$43.47	-44.86%	Sold -100.00% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $63.33 Current price: $42.44 P/L: -32.99% Sold -100.00% shares Q3 2022	share	0.00%	0	$63.33	$42.44	-32.99%	Sold -100.00% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $65.51 Current price: $121.22 P/L: +85.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$65.51	$121.22	+85.04%	Sold -100.00% shares Q3 2022
Biotechnology Immatics N.V. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $10.79 Current price: $11.13 P/L: +3.15% Sold -100.00% shares Q3 2022	share	0.00%	0	$10.79	$11.13	+3.15%	Sold -100.00% shares Q3 2022
Health Information Services Privia Health Group, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $23.52 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$23.52	N/A	Sold -100.00% shares Q3 2022

Showing TOP 78 REDMILE GROUP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of REDMILE GROUP, LLC?

The biggest position of the REDMILE GROUP, LLC is Fate Therapeutics, Inc. (FATE) with 11.26% portfolio share worth of 290.37M US dollars.

Top 5 REDMILE GROUP's holdings represent 32.68% of the portfolio:

Fate Therapeutics, Inc. (FATE) – 11.26%
Amicus Therapeutics, Inc. (FOLD) – 8.8%
Krystal Biotech, Inc. (KRYS) – 5.14%
argenx SE (ARGX) – 3.83%
Pliant Therapeutics, Inc. (PLRX) – 3.65%

Who is the portfolio manager of REDMILE GROUP, LLC?

The portfolio manager of the REDMILE GROUP, LLC is .

What is the total asset value of the REDMILE GROUP, LLC portfolio?

REDMILE GROUP, LLC total asset value (portfolio value) is 2.58B US dollars.

Who is ?

is the portfolio manager of the REDMILE GROUP, LLC.

What is (REDMILE GROUP, LLC) fund performance?

REDMILE GROUP's quarterly performance is +3.09%, annualy -50.83%. In the past 3 years, the value of 's portfolio has decreased by -30%. In the past 5 years, the value of the portfolio has decreased by -71%.

What is the REDMILE GROUP, LLC CIK?

REDMILE GROUP's Central Index Key is 0001425738 .

REDMILE GROUP, LLC Holdings

REDMILE GROUP, LLC portfolio value:

REDMILE GROUP, LLC quarter portfolio value change:

REDMILE GROUP, LLC 1 year portfolio value change:

REDMILE GROUP, LLC 3 years portfolio value change:

REDMILE GROUP, LLC 5 years portfolio value change: